The company iDelivery iSrl, which operates in the biotechnology sector, was established in 2013 and is one of the first companies registered in the register of innovative startups in the province of Reggio Calabria. of research and universities that will lead in 2014 to the creation of an innovative "nanocarrier", for the administration of active drugs inside the hair follicle, which allows him to obtain the second prize at the Start Cup Calabria and access to the final of the final of the National Award Innovation 2014 where it ranks among the top four absolute finalists. Subsequently, the project will be patented and will take the name of Bulbixin®. In 2015 the company was selected to participate in some national and international acceleration courses such as: Unicredit Start Lab, JCube and Mercks Innovation Center. In the same period, it provides consulting services to Italian players in the pharmaceutical sector and reinvests the proceeds to take over the exclusive management and development of an Italian patent that allows the use of a natural active ingredient for the topical treatment of psoriatic plaques, which was given the name of Lenipsor +. Also in 2015 he was awarded the Innovation Award of the Chamber of Commerce of Reggio Calabria for the Bulbixin® project. In the following years the Lenipsor + ® patent was extended to the USA, Europe, Japan.
The 100% Made in Italy Certification provides consumers with the guarantee on the Italian orgin and the quality of purchased products.
Manufacturers issued with the 100% Made in Italy Certification undergo a series of checks in order to verify that the entire production cycle takes place in Italy.
The Certification follows the directives set in current Italian laws.